Search

everythinglearnresearchcommunity

for

Search:↓

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Lyophilized platelet-rich plasma is beneficial and effective for various medical treatments, including tissue regeneration and hair regrowth.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Some people lose a lot of hair after having COVID-19.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Most Facebook posts about hair loss treatments are promotional and not medically supported, with better quality information found on YouTube.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.